Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-24T11:54:44.525Z Has data issue: false hasContentIssue false
  • English
  • Français

Selective Deficits in Alzheimer and Parkinsonian Dementia: Visuospatial Function

Published online by Cambridge University Press:  18 September 2015

Erich Mohr ,
Irene Litvan ,
Jill Williams ,
Paul Fedio  and
Thomas N. Chase
Erich Mohr*
Affiliation:
Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Irene Litvan
Affiliation:
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Jill Williams
Affiliation:
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Paul Fedio
Affiliation:
Medical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD
Thomas N. Chase
Affiliation:
Experimental Therapeutics Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD
*
Royal Ottawa Hospital, Neuropsychology Service, 1145 Carling Avenue, Ottawa, Ontario K1Z 7K4
Rights & Permissions [Opens in a new window]

Abstract:

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Deficits in visuospatial cognition are frequently cited as an important component of the cognitive changes accompanying Parkinson's disease. To characterize possible differences between Parkinson's (PD) and Alzheimer's (AD) dementia, patients from both groups, matched for overall dementia severity, age and education, were contrasted neuropsychologically. Visuospatial tasks dissociated from memory, were significantly compromised in both patient groups. Differential impairment was evident on visuospatial abstraction and reasoning (Object Assembly), which was most deficient in PD. Visuospatial cognition associated with memory, classified both patient groups as impaired compared to controls, but AD patients demonstrated substantially lower performance levels than those with PD. Parkinsonian dementia thus appears to have some distinct features compared to Alzheimer's disease, which may indicate differences in underlying pathogenic mechanisms.

Résumé:

RÉSUMÉ:

Des déficits dans la cognition visuospatiale sont souvent cités comme étant une composante importante des changements cognitifs accompagnant la maladie de Parkinson. Afin de caractériser les différences possibles entre la démence de la maladie de Parkinson (MP) et celle de la maladie d'Alzheimer (MA), des patients de chacun de ces deux groupes, appariés pour la sévérité globale de la démence, l'âge et le niveau d'éducation, ont été comparés au point de vue neuropsychologique. Les tâches visuospatiales dissociées de la mémoire étaient significativement compromises dans les deux groupes de patients. Une atteinte différentielle était évidente au niveau de l'abstraction visuospatiale et du raisonnement (assemblage d'objets), cette atteinte étant plus marquée dans la MP. La cognition visuospatiale associée à la mémoire classifiait les deux groupes de patients comme atteints lorsqu'ils étaient comparés aux contrôles, mais les patients avec MA avaient des niveaux de performance plus bas que ceux des patients avec MP. La démence parkinsonienne semble donc posséder des caractéristiques distinctes comparativement à celles de la maladie d'Alzheimer, ce qui peut indiquer des différences sous-jacentes aux mécanisms pathogéniques.

Type
Original Articles
Information
Canadian Journal of Neurological Sciences , Volume 17 , Issue 3 , August 1990 , pp. 292 - 297
Copyright
Copyright © Canadian Neurological Sciences Federation 1990

References

REFERENCES

1. Brown, RG, Marsden, CD. “Subcortical dementia”: the neuropsychological evidence. Neuroscience 1988; 25: 363–387.CrossRefGoogle ScholarPubMed
2. Sahakian, BJ, Morris, RG, Evenden, JL, et al. A comparative study of visuospatial memory and learning in Alzheimer-type dementia and Parkinson’s disease. Brain 1988; 111: 695–718.CrossRefGoogle ScholarPubMed
3. Mohr, E, Fabbrini, G, Williams, J, et al. Dopamine and memory function in Parkinson’s disease. Movement Disorders 1989; 4: 113–120.CrossRefGoogle ScholarPubMed
4. Agid, Y, Ruberg, M, Dubois, B, et al. Parkinson’s disease and dementia. Clin Neuropharmacol 1986; 9: S22–S36.CrossRefGoogle ScholarPubMed
5. Teraevaeinen, H, Hietanen, M, Stoessl, J, et al. Dementia in movement disorders. Can J Neurol Sei 1986; 13: 546–558.CrossRefGoogle Scholar
6. Alvord, EC, Forno, LS, Kusske, JA, et al. The pathology of parkinsonism: a comparison of degenerations in the cerebral cortex and brain stem. Adv Neurol 1974; 5: 175–193.Google Scholar
7. Hakim, AM, Mathieson, G. Dementia in Parkinson’s disease: a neuropathologic study. Neurology 1979; 29: 1209–1214.CrossRefGoogle ScholarPubMed
8. Boller, F, Mizutani, T, Roessmann, U, et al. Parkinson disease, dementia and Alzheimer’s disease: clinicopathologic correlates. Ann Neurol 1980; 7: 329–335.CrossRefGoogle Scholar
9. Chui, CH, Mortimer, JA, Slager, U, et al. Pathologie correlates of dementia in Parkinson’s disease. Arch Neurol 1986; 43: 991’995.CrossRefGoogle Scholar
10. Jellinger, K. Neuropathological substrates of Alzheimer's disease and Parkinson’s disease. J Neural Transm 1987; 24: 109–129.Google ScholarPubMed
11. Dubois, B, Danze, F, Pillon, B, et al. Cholinergic-dependent cognitive deficits in Parkinson’s disease. Ann Neurol 1987; 22: 26–30.CrossRefGoogle ScholarPubMed
12. Lichter, DG, Corbett, AJ, Fitzgibbon, GM, et al. Cognitive and motor dysfunction in Parkinson’s disease. Clinical, performance and computed tomographic correlations. Arch Neurol 1988; 45: 854–860.CrossRefGoogle ScholarPubMed
13. Huber, SJ, Shuttleworth, EC, Paulson, GW. Dementia in Parkinson’s disease. Arch Neurol 1986; 43: 987–990.CrossRefGoogle ScholarPubMed
14. Boller, F, Passafiume, D, Keefe, NC, et al. Visuospatial impairment in Parkinson’s disease: the role of perceptual and motor factors. Arch Neurol 1984; 41: 485–490.CrossRefGoogle ScholarPubMed
15. Brown, RG, Marsden, CD. Visuospatial function in Parkinson’s disease. Brain 1986; 109: 987–1002.CrossRefGoogle ScholarPubMed
16. Mohr, E, Juncos, J, Cox, C, et al. Selective deficits in cognition and memory in high-functioning Parkinsonian patients. J Neurol Neurosurg Psychiatry; in press.Google Scholar
17. Mattis, S. Mental status examination for organic mental syndrome in the elderly. In: Bellack, L, Karasu, TB, eds. Geriatric Psychiatry. New York: Grune and Stratton 1976; 77–121.Google Scholar
18. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. American Psychiatric Association 1987. Third ed. revised. Washington, D.C.Google Scholar
19. McKhann, G, Drachman, D, Folstein, M, et al. Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspice of Department of Health and Human Services task force on Alzheimer’s disease. Neurology 1984; 34: 939–944.CrossRefGoogle ScholarPubMed
20. Fahn, S, Marsden, CD, Calne, D, et al. Recent developments in Parkinson’s disease. New Jersey, Macmillan Health Care Information 1987; 293–304.Google Scholar
21. Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.CrossRefGoogle ScholarPubMed
22. Wechsler, D. Wechsler Adult Intelligence Scale-Revised. New York, The Psychological Corporation 1981.Google Scholar
23. Wechsler, D, Stone, CP. Wechsler Memory Scale. New York, The Psychological Corporation 1945.Google Scholar
24. Bruno, G, Mohr, E, Gillespie, M, et al. Muscarinic agonist therapy of Alzheimer’s disease: a clinical trial of RS-86. Arch Neurol 1986; 43: 659–661.CrossRefGoogle ScholarPubMed
25. Brouwers, P, Cox, C, Martin, A, et al. Differential perceptual spatial impairment in Huntington’s and Alzheimer’s dementias. Arch Neurol 1984; 41: 1073–1076.CrossRefGoogle ScholarPubMed
26. Money, JA. Standardized Road Map of Direction Sense. San Rafael California: Academic Therapy Publications 1976.Google Scholar
27. Rey, A. L’examen psychologique dans le cas d’encephalopathie traumatique. Archives de Psychologie 1941; 28: 286–340.Google Scholar
28. Osterrieth, PA. Le test de copie d’une figure complexe: contribution l’etude de la perception et de la memoire. Archives de Psychologie 1944; 30: 206–356.Google Scholar
29. Heaton, R. Wisconsin Card Sorting Test Manual. Odessa, Florida, Psychological Assessment Resources 1981.Google Scholar
30. Litvan, I, Mohr, E, Williams, J, et al. Differential memory and executive functions in demented patients with Parkinson’s and Alzheimer disease. Journal Neurol Neurosurg Psychiatry; in press.Google Scholar
31. Brown, MD, Engelman, L, Frane, JW, et al. BMDP Statistical Software, Los Angeles, University of California 1985; 59–412.Google Scholar
32. Cummings, JL, Darkins, A, Mendez, M, et al. Alzheimer’s disease and Parkinson’s disease: comparison of speech and language alterations. Neurology 1988; 38: 680-–684.CrossRefGoogle ScholarPubMed
33. Stuss, DT, Benson, DF. The frontal lobes. New York: Raven Press, 1986.Google Scholar
34. Lezak, MD. Neuropsychological assessment, second edition. New York: Oxford University Press, 1983; 280–283.Google Scholar
35. Squire, LR, Cohen, NJ. Human memory and amnesia. In: Lynch, G, McGaugh, JL, Weinberger, NM, eds. Neurobiology of learning and memory. New York: Guilford Press, 1984; 40.Google Scholar
36. Gotham, AM, Brown, RG, Marsden, CD. ‘Frontal’ cognitive function in patients with Parkinson’s disease ‘on’ and ‘off’ levodopa. Brain 1988; 111: 299–321.CrossRefGoogle ScholarPubMed
37. Alexander, GE, DeLong, MR, Strick, PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Ann Rev Neurosci 1986; 9: 357–81.CrossRefGoogle ScholarPubMed
38. Chase, TN, Burrows, GH, Mohr, E. Cortical glucose utilization patterns in primary degenerative dementias of the anterior and posterior type. Arch Gerontol Geriatr 1987; 6: 289–97.CrossRefGoogle ScholarPubMed
39. Mann, UM, Mohr, E, Chase, TN. Rapidly progressive Alzheimer’s disease. The Lancet; 1989; 2: 799.CrossRefGoogle ScholarPubMed
40. Mohr, E, Fabbrini, G, Ruggieri, S, et al. Cognitive concomitants of dopamine system stimulation in Parkinsonian patients. J Neurol Neurosurg Psychiatry 1987; 50: 1192–1196.CrossRefGoogle ScholarPubMed
41. Ferris, S, Reisberg, B, Crook, T, et al. Pharmacologic treatment of senile dementia: choline, L-Dopa, piracetam and choline plus piracetam. In: Corkin, S, Davis, K, Growden, J, Usdin, E, Wurtman, R, eds. Alzheimer’s disease: a report of progress. New York: Raven Press, 1982.Google Scholar
42. Adolfsson, R, Gottfries, CG, Roos, BE, et al. Changes in brain catecholamines in patients with dementia of Alzheimer type. Brit J Psychiat 1979; 135: 216–23.CrossRefGoogle ScholarPubMed
43. Perry, EK, Tomlinson, BE, Blessed, G, et al. Neuropathological and biochemical observations on the noradrenergic system in Alzheimer’s disease. J Neurol Sci 1981; 51: 279–287.CrossRefGoogle ScholarPubMed
44. Rossor, M, Wersen, LL. Non-cholinergic neurotransmitter abnormalities in Alzheimer’s disease. Br Med Bull 1986; 42: 70–74.CrossRefGoogle ScholarPubMed
45. Cash, R, Dennis, T, L'Heureux R, et al. Parkinson’s disease and dementia: norepinephrine and dopamine in locus ceruleus. Neurology 1987; 37: 42–46.CrossRefGoogle Scholar
46. Randt, CT, Quartermain, D, Goldstein, M, el al. Norepinephrine biosynthesis inhibition: effects on memory in mice. Science 1971; 172: z498–9.CrossRefGoogle ScholarPubMed
47. Kety, SS. The possible role of the adrenergic systems of the cortex in learning. Res Publ Assoc Res Nerv Ment Dis 1972; 50: 376–89.Google ScholarPubMed
48. Stein, L, Belluzzi, JD, Wise, CD. Memory enhancement by central administration of norepinephrine. Brain Res 1975; 84: 329–35.CrossRefGoogle ScholarPubMed
49. Perry, EK, Tomlinson, BE, Blessed, G, et al. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 1978; 2: 1457–1459.CrossRefGoogle ScholarPubMed
50. Perry, EK. The cholinergic hypothesis — ten years on. Br Med Bull 1986; 42: 63–69.CrossRefGoogle Scholar
51. Mohr, E, Chase, TN. Treatment stategies in primary degenerative dementias. In: Boller, F., Grafman, J. eds. Handbook of Neuropsychology, Volume 5: Aging and Dementia. Amsterdam: Elsevier, 1990; in press.Google Scholar